ETC
GH icon

Exchange Traded Concepts’s Guardant Health GH Stock Holding History

Exchange Traded Concepts’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
8,782
-2,651
-23% -$288K 0.01% 844
2026
Q1 		$1.06M Buy
11,433
+1,015
+10% +$102K 0.01% 790
2025
Q4 		$1.06M Sell
10,418
-5,166
-33% -$462K 0.01% 782
2025
Q3 		$974K Sell
15,584
-1,982
-11% -$108K 0.01% 786
2025
Q2 		$914K Sell
17,566
-5,536
-24% -$247K 0.01% 715
2025
Q1 		$984K Sell
23,102
-2,908
-11% -$125K 0.02% 565
2024
Q4 		$795K Sell
26,010
-14,999
-37% -$422K 0.02% 661
2024
Q3 		$941K Buy
41,009
+5,160
+14% +$146K 0.02% 539
2024
Q2 		$1.04M Sell
35,849
-19,439
-35% -$453K 0.03% 430
2024
Q1 		$1.14M Buy
55,288
+17,592
+47% +$377K 0.03% 413
2023
Q4 		$1.02M Buy
37,696
+2,042
+6% +$53.6K 0.03% 399
2023
Q3 		$1.06M Sell
35,654
-9,634
-21% -$339K 0.03% 379
2023
Q2 		$1.62M Sell
45,288
-2,279
-5% -$65.5K 0.04% 299
2023
Q1 		$1.11M Buy
47,567
+18,040
+61% +$515K 0.03% 310
2022
Q4 		$803K Buy
29,527
+727
+3% +$33.3K 0.02% 335
2022
Q3 		$1.55M Sell
28,800
-13,364
-32% -$686K 0.05% 179
2022
Q2 		$1.7M Buy
42,164
+6,820
+19% +$338K 0.05% 190
2022
Q1 		$2.34M Buy
35,344
+6,327
+22% +$433K 0.05% 199
2021
Q4 		$2.9M Buy
+29,017
New +$3M 0.06% 201
2021
Q2 		– Sell
-118
Closed -$18K – 1154
2021
Q1 		$18K Sell
118
-138
-54% -$20.9K ﹤0.01% 911
2020
Q4 		$33K Buy
256
+207
+422% +$23.8K ﹤0.01% 783
2020
Q3 		$5K Buy
49
+29
+145% +$2.65K ﹤0.01% 770
2020
Q2 		$2K Buy
+20
New +$1.61K ﹤0.01% 714

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Exchange Traded Concepts's GH Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Guardant Health (GH) stake by 23% in Q2 2026, selling an estimated $288K and leaving 8,782 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #844.

Exchange Traded Concepts first reported a position in GH in Q2 2020 and has held it in 23 quarters since. The position peaked at $2.9M in Q4 2021. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Exchange Traded Concepts held 8,782 shares of Guardant Health worth $1.32M as of Q2 2026.
  • Exchange Traded Concepts sold 2,651 Guardant Health shares in Q2 2026, an estimated $288K.
  • Guardant Health made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #844 holding.
  • Exchange Traded Concepts first reported a position in Guardant Health in Q2 2020 and has held it in 23 quarters since.
  • Exchange Traded Concepts's Guardant Health position peaked at $2.9M in Q4 2021.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.